Skip to main content
Top

Supportive Care in Cancer

Issue 1/1999

Content (12 Articles)

ORIGINAL ARTICLE

Pamidronate treatment in patients with malignant osteolytic bone disease and pain

D. Koeberle, L. Bacchus, B. Thuerlimann, H.-J. Senn

ORIGINAL ARTICLE

Assessing suspected spinal cord compression

J. A. Talcott, P. C. Stomper, Frank W. Drislane, Patrick Y. Wen, Caroline C. Block, Charles C. Humphrey, C. Lu, Ferenc Jolesz

SHORT COMMUNICATION

Oral cisapride for the control of delayed vomiting following high-dose cisplatin

Barbara A. Pizzo, Katherine M. W. Pisters, Vincent A. Miller, Stefan C. Grant, Lorraine Baltzer, Linda Hinckley, Mark G. Kris

ORIGINAL ARTICLE

Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol

V. Krcmery Jr., František Mateička, Alena Kunová, Stanislav Špánik, Ján Gyarfáš, Zuzana Syčová, Ján Trupl

SHORT COMMUNICATION

When all else fails: stepwise multiple solutions for a complex cancer pain syndrome

S. Mercadante, R. Serretta, M. Sapio, P. Villari, L. Calderone

SHORT COMMUNICATION

Must we really fear toxicity of conventional amphotericin B in oncological patients?

Jiří Mayer, Michael Doubek, J. Vorlíček

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine